Labat Africa starts recruitment for its first cannabis trial
Study will involve participants taking opioids for pain management who are willing to switch to cannabis
21 June 2022 - 18:54
Labat Africa, an investment company looking to take advantage of rising demand for cannabis-derived products, has started recruiting people for its first clinical cannabis trial in SA.
Labat’s East London research subsidiary Biodata will run the Pharma Ethics Observational Study in order to test whether cannabis can replace opioids for managing chronic pain, the company said in a statement on Tuesday...
BL Premium
This article is reserved for our subscribers.
A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
Already subscribed? Simply sign in below.
Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now